Advertisement
BMC Public Health volume 23, Article number: 1003 (2023)
1147
6
Metrics details
A recurrent feature of infectious diseases is the observation that different individuals show different levels of secondary transmission. This inter-individual variation in transmission potential is often quantified by the dispersion parameter k. Low values of k indicate a high degree of variability and a greater probability of superspreading events. Understanding k for COVID-19 across contexts can assist policy makers prepare for future pandemics.
A literature search following a systematic approach was carried out in PubMed, Embase, Web of Science, Cochrane Library, medRxiv, bioRxiv and arXiv to identify publications containing epidemiological findings on superspreading in COVID-19. Study characteristics, epidemiological data, including estimates for k and R0, and public health recommendations were extracted from relevant records.
The literature search yielded 28 peer-reviewed studies. The mean k estimates ranged from 0.04 to 2.97. Among the 28 studies, 93% reported mean k estimates lower than one, which is considered as marked heterogeneity in inter-individual transmission potential. Recommended control measures were specifically aimed at preventing superspreading events. The combination of forward and backward contact tracing, timely confirmation of cases, rapid case isolation, vaccination and preventive measures were suggested as important components to suppress superspreading.
Superspreading events were a major feature in the pandemic of SARS-CoV-2. On the one hand, this made outbreaks potentially more explosive but on the other hand also more responsive to public health interventions. Going forward, understanding k is critical for tailoring public health measures to high-risk groups and settings where superspreading events occur.
Peer Review reports
Since the emergence of the novel coronavirus SARS-CoV-2 in late 2019 and the declaration of a public health emergency of international concern by the WHO on 30th January 2020 [1], more than 670 million cases have been recorded as of February 2023 [2]. Numerous efforts have been made to mitigate onward transmission. Knowledge about dispersion characteristics are indispensable for public health policy as it allows tailored control measures, and understanding dispersion may be critical for future pandemics.
The dispersion parameter k is an estimate of the dispersion in the number of secondary transmissions generated by each case. It is critical to estimating the probability of superspreading events in which certain individuals infect unusually large numbers of secondary cases [3]. Lloyd-Smith et al. first described that the distribution of individual transmission potential around the basic reproduction number R0 is frequently right skewed or overdispersed [3, 4]. They introduced the dispersion parameter k that indicates the variance in the number of offspring based on a Negative Binomial distribution [3]. Hence, k can be described as the variation in inter-individual transmission potential whereby low values of k represent higher variation and larger probability of superspreading events.
The ‘20/80 rule’ is a rule of thumb that emphasises the level of variance typically observed in infectious disease transmission: it is not uncommon that only about 20% of primary cases cause 80% of onward transmission [5]. In sexually transmitted and vector-borne diseases, studies often indicate the percentage of most infectious primary cases that account for 80% of secondary cases, serving as a surrogate marker for heterogeneity in individual infectiousness [5].
If a disease spreads homogeneously, the variance around the base reproduction number R0 is low, k approaches infinity and the distribution of secondary cases approaches Poisson (Fig. 1A). Each case transmits the pathogen onto the next generation rather equally. In this scenario, broad population-wide control measures are necessary and the disease is more difficult to contain [3]. Contrarily, a heterogeneous offspring distribution exhibits a wider dispersion around R0 and k is smaller than one. In this scenario, superspreading events are more likely to occur and become a major concern (Fig. 1B). Large outbreaks happen less frequently but can become more explosive [3]. In this case, by focusing on specific settings or high-risk groups where superspreading occurs, for example large gatherings indoors or people of a certain age group, better containment of virus spread could be achieved without imposing population-wide control measures. Simultaneously, the probability of extinction of the disease is more likely as more cases have no offspring at all.
Conceptual framework. Homogeneous and heterogeneous patterns of disease transmission require different control measures. A: Every infected individual passes on the disease to two other people on average, R0 equals two, k approaches infinity, secondary cases show a Poisson distribution with mean and variance equal to R0. As a consequence, Public Health aims at population-wide control measures. B: Infected individuals show different levels of secondary transmission, R0 equals two as in scenario A, but contrastingly k is smaller than one. Secondary cases show a Negative Binomial distribution. Public health measures can target high risk groups or settings where superspreading is likely to occur. Figure created with BioRender.com
Where the majority of cases does not contribute to onward transmission, the effective reproduction number could be substantially reduced by preventing superspreading events [6, 7]. In other words, public health interventions that specifically target settings where superspreading events occur could rapidly reduce overall transmission [8]. With high levels of superspreading, individual specific control measures targeting risk groups are likely to outperform population-wide interventions [9].
Infectious diseases with high levels of heterogeneity in transmission, in principle, should be easy to control with public health interventions [10] and this heterogeneity can even be advantageous for control measures [11]. However, this all depends on the ability to effectively identify and reduce transmission related behavior in those populations spreading the disease, without stigmatising those groups, and considering societal equity. Moreover, the effectiveness of measures will also critically depend on R0 and the speed to which any intervention can be implemented.
This study reviews the dispersion parameter k in the context of the SARS-CoV-2 (COVID-19) pandemic, taking into account all-group k estimates as well as values for different subgroups. Following on from this, recommendations for public health are assembled, which studies derived from the calculation of their dispersion parameter estimates. Our aim is to provide a summary that researchers and policy makers can use to better understand the characteristics of k and in doing so can inform future pandemics.
A review of the literature was undertaken using a systematic approach. On 4th August 2022 an online search was carried out for publications from 1st January 2020 to 4th August 2022 including the databases PubMed (via NCBI); EMBASE (via OVID); Web of Science; Cochrane Library. As a considerable proportion of work on SARS-CoV-2 / COVID-19 has been published as preprint articles, the “COVID-19 Portfolio” server of the National Institutes of Health (NIH) [12] was additionally searched for non-peer reviewed work filtering for the following databases: MedRxiv; BioRxiv; arXiv.
Three search components were set up for the literature review with the following key concepts: (A) “SARS-CoV-2”, (B) “superspreading” and (C) “dispersion”. Keywords were searched for in all databases (see Table 1). Subject heading searches were conducted in databases where available (in principle PubMed, Embase, Cochrane Library) and where appropriate MeSH terms were identified.
For further eligibility of literature the following inclusion criteria had to be met: The study was published on a peer-reviewed or non-peer-reviewed server; the study was based on real world data (e.g. epidemiological surveillance, contact tracing data, genetic analysis of patient samples); the study provided at least one all-group estimate for dispersion parameter k; the study was published between 1st January 2020 and 4th August 2022 in English or German language. Modelling studies were included when they drew on or were validated on epidemiological data.
This study both updated and extended a previously published review [13] in terms of study period covered and data extracted. In doing so, we aimed to expand the understanding of k in SARS-CoV-2 in the rapidly evolving pandemic by including most recent studies, capturing evidence on virus subtypes, but also obtaining k estimates in various subgroups. In addition, we compiled public health recommendations derived from calculated k estimates.
The systematic literature search identified a total of 675 studies (307 on databases for peer-reviewed and 368 on databases for pre-print articles) from 1st January 2020 to 4th August 2022. The Cochrane database search did not retrieve any record. A reference list search of the previous review [13] yielded an additional four studies that met inclusion criteria. 679 records were imported into EndNote software (Version X9 3.3). After removal of 201 duplicates by stepwise deduplication, the remaining 478 records were screened by title and abstract. 434 studies did not meet inclusion criteria (18 not related to SARS-CoV-2; 125 other SARS-CoV-2 related public health topics; 201 insufficient information on dispersion parameters; 69 other natural sciences topic; 18 single case reports; 1 non English/German language; 2 communications) and 44 studies were assessed further for eligibility. Among these, another 16 studies were excluded due to insufficient information on dispersion parameter estimates or pure focus on outbreak simulation. A total of 28 records was finally included in this study: We re-examined and extended data extraction of the 17 studies that were also included in the previous review [13]. Additionally, one major study of 2020 [14] not captured by the previous review was included as well as 10 newly identified and recently published studies (after 10/09/2021) for complete data extraction.
Quality appraisal of literature was of particular concern in this study as a significant number of non-peer reviewed, and therefore possibly not previously quality checked, COVID-19 work was expected to be eligible for inclusion according to the search strategy. The final set of identified studies was subjected to a critical quality appraisal checklist according to the Critical Appraisal Skills Programme (CASP) guidelines [15] and the quality of cross-sectional studies (AXIS) scale [16]. A set of 13 quality appraisal questions were grouped into the categories “introduction” (2 questions), “methods” (6), “results” (2) and “discussion” (3). The articles were scored based on positive units, ranging from strong (≥10/13 “YES”-units) and good (7-10/13) to weak (<7/13) quality (see supplement A). Emphasis was given to the assessment of the description of methods in order to ensure an a priori valid dispersion parameter calculation.
Articles finally included in this review were first classified by their study characteristics: Author, journal, publication date, title, type of method for estimation of k and type of dataset. Subsequently, epidemiological data was extracted: Estimate of dispersion parameter k; 95% confidence interval (CI) of dispersion parameter k; estimate of basic reproduction number R0; 95% CI of basic reproduction number R0; percentage of cases that is responsible for 80% of secondary cases (20/80 rule); population (size, contacts, clusters); information on analysis of subgroups/ clusters/ settings/ events; study period; and region/ country. Moreover, public health control measures that were recommended based on the identified dispersion characteristics were extracted as well as the type of virus investigated (wildtype vs. variant of concern (VOC)) (see supplement B). To investigate whether the dispersion of secondary cases differs in certain subgroups, available data on k estimates in subgroups was grouped into four categories for further analysis: (1) settings, (2) age of primary case, (3) symptoms at the time of disease transmission, and (4) pre/after public health intervention. Data extracted in this study was primarily used for descriptive and comparative analysis.
For studies that included an all-group mean k estimate, its 95% confidence interval and the number of cases studied (sample size), a meta-analysis was carried out to approximate a pooled global k value for SARS-CoV-2. The analysis included 32 values (obtained from 24 studies). Four studies (containing 8 all-group mean k estimates) were excluded for the pooled analysis because of lack of sample size [6, 17], confidence intervals [10], or both [18]. Two all-group mean k estimates in one study [19] were excluded as upper confidence intervals reached infinity and thus weight in the pooled estimate was considered negligible. The calculation of a global mean k estimate was performed using the inverse variance method for pooling. Hereby, studies containing larger sample sizes and small confidence intervals were given more weight. Obtaining high heterogeneity between values (I2 test for heterogeneity=100%), we subsequently employed a random effects model for the measurement of a global mean k estimate. Calculations were carried out in R (version 4.2.3), R-package ‘meta’.
The PRISMA flowchart shows the detailed study selection process (Fig. 2). Table 2 summarises the study characteristics of included studies, by author in alphabetical order.
Study selection process.
All 28 studies finally included were peer-reviewed publications. Any pre-print article that was identified within the study selection process was removed by deduplication as it had meanwhile been published in a peer-reviewed journal. Included studies were published between 2020 and 2022, with the first publication on SARS-CoV-2 superspreading dating to 30th January 2020 [17] and the most recent dating to 11th July 2022 [22]. The quality assessment by critical appraisal revealed high-quality studies (all scoring 10 or higher, see supplement C). The most frequent weakness was the lack of considering limitations in nine publications. The fact that any eligible pre-print article had been published in a peer-reviewed journal in the meantime supported the results of the quality appraisal of included studies.
The included studies performed their calculations using epidemiological data. Five categories of datasets could be identified: the first type of dataset was used by 7 studies and was based on contact tracing data. By asking patients with confirmed SARS-CoV-2 infection to document their close contacts with other infected patients, cases could be placed in a wider transmission network. Calculating the empirical offspring distribution led to an estimate of transmission heterogeneity. A second basis for estimating the dispersion in the population under study was surveillance data. Four studies exclusively used information from surveillance to infer transmission dynamics. In this kind of analysis, temporal and geographical coincidence of one or more index and secondary cases is used as a means to indirectly reconstruct clusters of cases. 13 studies used a combination of surveillance and contact tracing data (see Table 2). We did not observe any significant difference between all-group mean k estimates originating from contact tracing data, surveillance data or a combination of both (see supplement D). Thirdly, two studies drew on SARS-CoV-2 genomic sequences and used phylogenetic trees to deduce dispersion patterns [30, 36]. RNA viruses constantly mutate during replication and transmission. By sequencing the viral genome, epidemiological information can thus be obtained and mapped into transmission networks. As a fourth data source, a study investigating the variability of within household transmission, paired serological SARS-CoV-2 antibody test data with a household survey [10].The fifth type of dataset matched surveillance data (including demographic information and geolocation of the residence of cases) with aggregate high-volume mobility data of the population (obtained by Facebook users who enabled location services on their mobile phones) to infer viral spreading across the region [18].
In line with a common mode of measuring the heterogeneity of infectiousness and suggested by the pivotal paper of superspreading events in infectious diseases [3], most studies used a negative binomial distribution for the estimation of the dispersion parameter k [6,7,8, 10, 11, 14, 17,18,19,20,21,22,23,24, 26,27,28,29, 31,32,33,34,35, 37, 38]. In addition, one study quantified superspreading potential by using different mixture distributions and compared these to the negative binomial dispersion parameter: the authors suggest a cautious choice of the underlying data generating distribution as the mean in offspring and its variance can become skewed with increasing overdispersion if incorrect assumptions about the type of distribution are made [28]. Finally, two studies analysed genomic SARS-CoV-2 sequences obtained by patients’ samples and subsequently used these for phylodynamic analyses for the estimation of k [30, 36].
Studies investigated SARS-CoV-2 superspreading in 12 countries: China [9, 24, 36] (including specific reports on Hong Kong [9, 11, 19, 21, 28], Shenzhen [20], Tianjin [9, 37], Wanzhou [32] and the provinces of Hunan [33], Guangdong [38] and Shandong [35]), Denmark [6], France [8], India (regions of Karnataka [22], Tamil Nadu and Anda Pradesh [14, 28]), Israel [30], Indonesia [23] (Jakarta Depok, region of Batam), Japan [19, 27], New Zealand [26], Rwanda [28], Singapore [19, 34], South Korea [29, 31], and the United States of America (states of Georgia [18] and Utah [10]) (Fig. 3). Two studies examined patterns of SARS-CoV-2 transmission from a global perspective [7, 17].
Geographical mapping of reported k estimates. Shown are all-group point estimates of k. Colour-coding based on the countries’ values in the range of k. Created with mapchart.net
All studies provided a point estimate and 95% CI for the dispersion parameter k, indicating the extent of heterogeneity in disease transmission. 93 % of studies (26 of 28) reported mean k estimates lower than one and found a high degree of superspreading potential. Mean k estimates ranged from 0.04 (0.03, 0.04) [22] to 2.97 (2.86, 3.08) [30]. The median of reported mean k point estimates was 0.31. In total, 42 all-group point estimates of k were reported across 28 studies. Employing a weighted meta-analysis of 32 point estimates (of 24 studies), the global pooled mean estimate of k was 0.41 (0.23, 0.60). Figure 4A illustrates the all-group mean k estimates for all studies and the global pooled mean estimate. Table 3 shows all epidemiological data extracted from 28 publications. Paired estimates of R0 and k for each study are displayed in Fig. 5.
All-group point estimates of k and proportion of primary cases accounting for 80% of onward transmission. (A) All-group point estimates of k with 95% CI arranged in alphabetical order. Dashed line indicates mean, area in grey indicates 95% CI of global pooled estimate. Arrows indicate that upper 95% confidence interval reaches infinity. Point estimates in grey are not included in meta-analysis for global pooled estimate. B Proportion of most infectious primary cases that generate 80% of secondary casesarranged in alphabetical order. Dashed line indicates empirical ‘20/80 rule’.
R0 and corresponding k values. Shown are extracted R0 and corresponding k values (with 95% CI). Upper CI limit not depicted if reaching infinity.
Sixteen studies presented the fraction of most infectious that generate 80% of secondary cases in SARS-CoV-2, ranging from 8.7% to 32.3% (Fig. 4B). Nine studies found that percentages of less than 20% of cases accounted for 80% of onward transmission.
Five studies investigated the dispersion of SARS-CoV-2 infections in specific settings. High levels of overdispersion were present across all settings with mean k estimates ranging between 0.014 and 0.72 (Fig. 6A by setting, Fig. 6B by publication). Three studies identified k estimates in households and four at work with superspreading occurring somewhat less likely in the former than in the latter. Both religious gatherings and hospitals or convalescent homes were identified as risk settings for superspreading [22, 29, 35]. There was an increase in overdispersion and superspreading potential the less close the contacts were [33] (risk in ascending order: household, extended family, social contact and community contact). This result of high overdispersion following sporadic community contacts was consistent with low k values found for leisure facilities [29] and air transportation [35] in two other studies.
k and R0 estimates for different subgroups. A Analysis by cluster type/ setting (by setting). B Analysis by cluster type/ setting (by publication). C Analysis by age group. D Analysis by symptoms. E Analysis by public health interventions.
A Japanese study found low k estimates for all age groups throughout the entire study period which did not differ significantly. Of note, 80% of primary cases causing secondary transmission belonged to the age group of 20-69 years [27]. The other study stratifying k for age groups reported that children under 10 years played less of a role in the spread of SARS-CoV-2 than adults. With a mean reproduction number of 0.87 (versus 1.49 and 1.51 for adults and elderly people, respectively) and a mean k estimate of 3.17 (versus 0.7 and 0.5 for adults and elderly people, respectively), they generated fewer secondary cases on average and were less likely to be superspreaders [26] (Fig. 6C). Another study divided into two age groups above and below 60 years of age. Though not directly calculating k values, it showed that the average of the mean number of offspring in the age group under 60 years is 2.78 (2.10, 4.22) times larger than in elderly cases and that younger people therefore tended to generate more extreme numbers of offspring [18].
Two studies distinguished between asymptomatic and symptomatic cases. The basic reproduction number was significantly lower in asymptomatic than in symptomatic cases, but overdispersion was higher in the asymptomatic group [22]. Except for the first of transmission generations, a lower R0 in asymptomatic cases was also observed in the other study, which, however, did not determine k values [32] (Fig. 6D).
Two studies examined whether heterogeneity in individual infectiousness is affected by pandemic control measures. In the first study, after interventions (traffic restriction, quarantine measures) had taken effect, a lower transmission potential and heterogeneity (decrease in R0 and increase in k) was observed [37]. The second study also found a decrease in R0 after alert level introduction (curfews, shutdown of business and schools), but contrarily showed an associated decrease in k across all age groups [26], but if this decrease in k under public health interventions resulted in more superspreading events was not discussed (Fig. 6E).
Three studies focused on the SARS-CoV-2 variants of concern Delta and Omicron, respectively. Delta is attributed a higher superspreading potential (k=0.26) by the first publication, compared to that of the wild-type in the early pandemic outbreaks [38]. The authors emphasised the risk of superspreading if Delta entered areas with low herd immunity or places where many people meet. The second study analysed the change in transmission dynamics as Delta became the dominant variant in South Korea. A slight increase in k was identified here (0.64 and 0.85 before and at predominance, respectively) [31]. One study looked at heterogeneity in transmission of the Omicron variant and found overdispersed transmission. Compared to Omicron subtype BA.1, the more recent subtype BA.2 has an even greater superspreading potential [21]. The authors hypothesise that the observation of greater susceptibility to superspreading might be explained with low prevalence of vaccination boosters at the time of investigation and only limited natural immunity due to a ‘zero COVID-19’ policy in Hong Kong [21].
Table 4 categorises and lists all public health interventions recommended in the reviewed papers, as stated in the publications, regardless of their feasibility, societal or legal/ human rights implications. The strategy to specifically ban large gatherings and limit capacity in indoor spaces was the most recommended, followed by targeting high-risk groups and large close contact groups. In the category of surveillance and contact tracing, the need for rapid tracing and quarantine for contacts was most frequently suggested. One study that calculated a mean k point estimate also addressed backward tracing as an approach to mitigate viral spread. Population-wide control measures like wearing face-masks and vaccination were also among the recommendations to reduce viral spread despite an overdispersed transmission pattern.
We find here a wide range of work that estimates the heterogeneity in transmission of SARS-CoV-2 and overall, we find consistent evidence of high level of overdispersion across settings. This suggests that public health measures that focus on risk groups may have been effective at slowing transmission, where the disease had not been evenly spreading among the general population.
Heterogeneity in SARS-CoV-2 transmission was present in the early outbreaks of the pandemic as well as in the latest observations and across different variants. Our compilation of k estimates for subgroups classified according to different criteria showed that superspreading occurs across all age groups and in a wide variety of settings. Children may seem to be less heterogeneous transmitters though the number of studies stratifying for age was limited. By contrast, asymptomatic carriers can be particularly hazardous, as they showed more heterogeneous transmission patterns and can thus also contribute to superspreading.
Going forward, a common approach in early pandemic response measures is the so-called backward tracing of cases, recommended by one study [22], in which not only possible contacts of the infected individual are notified, but also the origin of infection is traced back to the index case. This method helps to identify clusters and was largely adopted by Japan in the first wave of infections [27, 39]. Cluster based approaches were shown to be effective in preventing superspreading events and help to terminate transmission chains, where done very promptly [27]. In the case of COVID-19, we found one modelling study comparing backward and forward tracing methods. It suggested that primary cases identified by backward tracing may generate 3-10 times more infections than those identified by forward tracing [40]. The proportion of secondary cases thereby averted was estimated to two to threefold and effectively contributed to outbreak control. These findings are a reminder, that early rapid control efforts can be pivotal even in pathogens with high levels of infectiousness.
Nevertheless, SARS-CoV-2 transmission highlighted the challenge for non-pharmaceutical interventions to specifically target risk groups and settings [11, 30, 37]. As demonstrated in the subgroup analysis, superspreading events occurred in a large variety of settings. In retrospect, heterogeneity of infectiousness was equally present within households and at work. Nevertheless, special attention should probably be paid in pandemic response planning to known indoor and special risk settings (e.g. care facilities, prisons, food processing plants, cruise ships, and large gatherings [41]), as proposed by most of the reviewed studies.
The general observation of overdispersion in SARS-CoV-2 transmission seems to be very robust. Estimates for k were reported across different countries, time points, populations and different viral strains. Moreover, different datasets and methods have been applied for calculations. Together with the presence of study cohorts with large sample sizes, reported estimates of k seemed consistent and plausible overall. However, the dispersion parameter from one region cannot necessarily be transferred to another as populations differ in general composition, immunity level and control measures in place. Interestingly though, the age distribution of a population on a nationwide scale was not likely to be associated with SARS-CoV-2 superspreading potential. In 2020, the median age of reviewed countries ranged from 20.3 years (Rwanda) to 48.2 (Japan) years [42]. The respective k estimates did not correlate with median age across countries.
This study has several limitations. Firstly, the scope of our review did not include direct assessment of the quality of statistical measurements of reviewed publications or the quality of the source datasets. It was also beyond the scope of this work to reconstruct quantities of interest (e.g. for k, R0 or the 20/80 rule) that were not reported in the reviewed studies. These mean that we assumed that all the reported estimates were statistically sound and accurate. Secondly, reported estimates are from datasets collected in various time points in the pandemic under different levels of interventions and/or behavioural changes, which could have deviated the estimates from the “baseline” SARS-CoV-2 dispersion patterns. Moreover, with a growing number of vaccinated individuals from the end of 2020 onward, the virus no longer encounters a fully susceptible population. For these reasons, k estimates would only reflect real-world conditions at the time of investigation. Thirdly, under lockdowns, superspreading events were by default only possible where people were still allowed to meet (e.g. in households or at work). Data on superspreading events in settings that were under restriction (e.g. concert halls, theatres) has been limited. Fourth, being conducted in the middle of a pandemic, the included studies were mostly retrospective and secondary by nature. As the data was primarily collected for other purposes than estimating k (e.g. case isolation), possible estimation approaches were restricted by available data types. Estimates of k may have been more likely to be reported from settings where the collected data was incidentally suitable for estimation, which could be a source of bias. Estimating k is most straightforward when the distribution of the number of secondary transmissions per case is available, e.g. through contact tracing. In such instances, k can be estimated simply by fitting a negative binomial distribution to the observed data. Most of the studies included in our review used this approach and the pooled estimate may have been subject to limitations associated with the data collection, e.g. unidentified epidemiological links. Although some modelling approaches could estimate k from other (less informative) types of data, e.g. cluster sizes [7, 43], they seem to have been rarely used for COVID-19 data, potentially due to data access and technical hurdles. Finally, most studies were conducted before the emergence of variants of concern (VOC); only few studies estimated parameters for VOCs including Delta and Omicron. These variants might have different epidemiological characteristics than wild type SARS-CoV-2. Two of the included studies analysed data containing the Delta variant and only one study covered the Omicron variant, which left the evidence for these variants unestablished.
Taken together, our findings highlight the importance to consider the two key metrics of transmission potential – R0 and k – in parallel in preparing for control measures and to weigh these against each other. There is no “one-fits-all” approach, but in general early indications of overdispersed offspring distribution warrants implementation of targeted measures to mitigate pandemic spread and especially control superspreading events. Approaches for real-time monitoring of transmission heterogeneity and simultaneous estimation of R0 and k from incidence data are currently being explored [44] and should be fully incorporated in surveillance systems.
In summary, the systematic literature review for superspreading events in the SARS-CoV-2 pandemic with epidemiological characterisation of transmission patterns yielded dispersion parameter estimates that were mostly smaller than one, indicating a high superspreading potential. A combination of forward and backward contact tracing, timely confirmation of cases, rapid case isolation, vaccination, and preventive measures were suggested to be important measures for outbreak control and the suppression of superspreading events. Further investigations have to be performed to analyse new SARS-CoV-2 variants of concern, in particular Omicron subvariants, as data for heterogeneity in transmission is still limited here. Future research will also need to elucidate heterogeneity in transmission in African and Latin American countries for a global picture of dispersion patterns. It should be determined how k is affected in populations of partially vaccinated or recovered people, in particular in remaining susceptibles. Since parts of the population cannot be vaccinated, public health measures will then also have to prevent superspreading in these vulnerable groups.
All data generated or analysed during this study are included in this published article and its supplementary information files.
World Health Organization. COVID-19 Public Health Emergency of International Concern (PHEIC) Global research and innovation forum 2020 [Available from: https://www.who.int/publications/m/item/covid-19-public-health-emergency-of-international-concern-(pheic)-global-research-and-innovation-forum]. Last access: 07/02/2023
Center for Systems Science and Engineering (CSSE) Johns Hopkins University. COVID-19 Dashboard 2022 [Available from: https://coronavirus.jhu.edu/map.html]. Last access: 07/02/2023
Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature. 2005;438(7066):355–9.
Article CAS PubMed PubMed Central Google Scholar
Galvani AP, May RM. Dimensions of superspreading. Nature. 2005;438(7066):293–5.
Article CAS PubMed PubMed Central Google Scholar
Woolhouse MEJ, Dye C, Etard J-F, Smith T, Charlwood JD, Garnett GP, et al. Heterogeneities in the transmission of infectious agents: Implications for the design of control programs. Proc Natl Acade Sci. 1997;94(1):338–42.
Article CAS Google Scholar
Kirkegaard JB, Sneppen K. Superspreading quantified from bursty epidemic trajectories. Sci Rep. 2021;11(1):7.
Article Google Scholar
Endo A, Abbott S, Kucharski AJ, Funk S. Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China. Wellcome Open Res. 2020;5:67.
Article PubMed PubMed Central Google Scholar
Paireau J, Mailles A, Eisenhauer C, de Laval F, Delon F, Bosetti P, et al. Early chains of transmission of COVID-19 in France, January to March 2020. Eurosurveillance. 2022;27(6):12.
Article Google Scholar
Zhao S, Shen M, Musa SS, Guo Z, Ran J, Peng Z, et al. Inferencing superspreading potential using zero-truncated negative binomial model: exemplification with COVID-19. BMC Med Res Methodol. 2021;21(1):30.
Article CAS PubMed PubMed Central Google Scholar
Toth DJA, Beams AB, Keegan LT, Zhang Y, Greene T, Orleans B, et al. High variability in transmission of SARS-CoV-2 within households and implications for control. Plos One. 2021;16(11):21.
Article Google Scholar
Adam DC, Wu P, Wong JY, Lau EHY, Tsang TK, Cauchemez S, et al. Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong. Nat Med. 2020;26(11):1714–9.
Article CAS PubMed Google Scholar
National Institutes of Health. Covid19 Portfolio database. 2022 [Available from: https://icite.od.nih.gov/covid19/search/]. Last access: 07/02/2023
Du Z, Wang C, Liu C, Bai Y, Pei S, Adam DC, et al. Systematic review and meta-analyses of superspreading of SARS-CoV-2 infections. Transbound Emerg Dis. 2022;69(5):e3007-e14.
Laxminarayan R, Wahl B, Dudala SR, Gopal K, Mohan BC, Neelima S, et al. Epidemiology and transmission dynamics of COVID-19 in two Indian states. Science. 2020;370(6517):691–7.
Article CAS PubMed PubMed Central Google Scholar
Critical Appraisal Skills Programme. CASP Systematic Review Checklist. 2022 [Available from: https://casp-uk.net/casp-tools-checklists/]. Last access: 07/02/2023
Downes MJ, Brennan ML, Williams HC, Dean RS. Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open. 2016;6(12):e011458.
Article PubMed PubMed Central Google Scholar
Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill. 2020;25(4):2000058.
Article PubMed PubMed Central Google Scholar
Lau MSY, Grenfell B, Thomas M, Bryan M, Nelson K, Lopman B. Characterizing superspreading events and age-specific infectiousness of SARS-CoV-2 transmission in Georgia, USA. Proc Natl Acad Sci U S A. 2020;117(36):22430–5.
Article CAS PubMed PubMed Central Google Scholar
Kwok KO, Chan HHH, Huang Y, Hui DSC, Tambyah PA, Wei WI, et al. Inferring super-spreading from transmission clusters of COVID-19 in Hong Kong, Japan, and Singapore. J Hosp Infect. 2020;105(4):682–5.
Article CAS PubMed PubMed Central Google Scholar
Bi Q, Wu Y, Mei S, Ye C, Zou X, Zhang Z, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study. Lancet Infect Dis. 2020;20(8):911–9.
Article CAS PubMed PubMed Central Google Scholar
Guo Z, Zhao S, Lee SS, Mok CKP, Wong NS, Wang J, et al. Superspreading potential of COVID-19 outbreak seeded by Omicron variants of SARS-CoV-2 in Hong Kong. J Travel Med. 2022;29(6).
Gupta M, Parameswaran GG, Sra MS, Mohanta R, Patel D, Gupta A, et al. Contact tracing of COVID-19 in Karnataka, India: Superspreading and determinants of infectiousness and symptomatic infection. PLoS ONE. 2022;17(7 July):e0270789.
Article CAS PubMed PubMed Central Google Scholar
Hasan A, Susanto H, Kasim MF, Nuraini N, Lestari B, Triany D, et al. Superspreading in early transmissions of COVID-19 in Indonesia. Sci Rep. 2020;10(1):4.
Article Google Scholar
He DH, Zhao S, Xu XK, Lin QY, Zhuang Z, Cao PH, et al. Low dispersion in the infectiousness of COVID-19 cases implies difficulty in control. Bmc Public Health. 2020;20(1):4.
Article PubMed PubMed Central Google Scholar
Xu XK, Liu XF, Wu Y, Ali ST, Du Z, Bosetti P, et al. Reconstruction of transmission pairs for novel Coronavirus Disease 2019 (COVID-19) in Mainland China: estimation of superspreading events, serial interval, and hazard of infection. Clin Infect Dis. 2020;71(12):3163–7.
Article CAS PubMed PubMed Central Google Scholar
James A, Plank MJ, Hendy S, Binny RN, Lustig A, Steyn N. Model-free estimation of COVID-19 transmission dynamics from a complete outbreak. Plos One. 2021;16(3):13.
Article Google Scholar
Ko YK, Furuse Y, Ninomiya K, Otani K, Akaba H, Miyahara R, et al. Secondary transmission of SARS-CoV-2 during the first two waves in Japan: demographic characteristics and overdispersion. Int J Infect Dis. 2022;116:365–73.
Article CAS PubMed PubMed Central Google Scholar
Kremer C, Torneri A, Boesmans S, Meuwissen H, Verdonschot S, VandenDriessche K, et al. Quantifying superspreading for COVID-19 using poisson mixture distributions. Sci Rep. 2021;11(1):11.
Article Google Scholar
Lee H, Han C, Jung J, Lee S. Analysis of superspreading potential from transmission clusters of COVID-19 in South Korea. Int J Environ Res Public Health. 2021;18(24):13.
Article Google Scholar
Miller D, Martin MA, Harel N, Tirosh O, Kustin T, Meir M, et al. Full genome viral sequences inform patterns of SARS-CoV-2 spread into and within Israel. Nat Commun. 2020;11(1):5518.
Article CAS PubMed PubMed Central Google Scholar
Ryu S, Kim D, Lim JS, Ali ST, Cowling BJ. Serial Interval and transmission dynamics during SARS-CoV-2 delta variant predominance. South Korea Emerg Infect Dis. 2022;28(2):407–10.
Article CAS PubMed Google Scholar
Shi Q, Hu Y, Peng B, Tang XJ, Wang W, Su K, et al. Effective control of SARS-CoV-2 transmission in Wanzhou. China Nat Med. 2021;27(1):86–93.
Article CAS PubMed Google Scholar
Sun K, Wang W, Gao L, Wang Y, Luo K, Ren L, et al. Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2. Science. 2021;371(6526):eabe2424.
Article CAS PubMed Google Scholar
Tariq A, Lee Y, Roosa K, Blumberg S, Yan P, Ma S, et al. Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020. BMC Med. 2020;18(1):166.
Article CAS PubMed PubMed Central Google Scholar
Tsang TK, Fang LQ, Zhang AR, Jiang FC, Ruan SM, Liu LZ, et al. Variability in transmission risk of SARS-CoV-2 in close contact settings: a contact tracing study in Shandong Province. China Epidemics. 2022;39:8.
Google Scholar
Wang L, Didelot X, Yang J, Wong G, Shi Y, Liu WJ, et al. Inference of person-to-person transmission of COVID-19 reveals hidden super-spreading events during the early outbreak phase. Nat Commun. 2020;11(1):6.
Google Scholar
Zhang YJ, Li YY, Wang L, Li MY, Zhou XH. Evaluating transmission heterogeneity and super-spreading event of COVID-19 in a metropolis of China. Int J Environ Res Public Health. 2020;17(10):11.
Article Google Scholar
Zhao S, Guo ZH, Chong MKC, He DH, Wang MH. Superspreading potential of SARS-CoV-2 delta variants under intensive disease control measures in China. J Travel Med. 2022;29(3):2.
Article Google Scholar
Oshitani H. Cluster-based approach to coronavirus disease 2019 (COVID-19) response in Japan, from February to April 2020. Jpn J Infect Dis. 2020;73(6):491–3.
Article CAS PubMed Google Scholar
Endo A, Leclerc QJ, Knight GM, Medley GF, Atkins KE, Funk S, et al. Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreaks. Wellcome Open Res. 2020;5:239.
Article PubMed Google Scholar
Althouse BM, Wenger EA, Miller JC, Scarpino SV, Allard A, Hebert-Dufresne L, et al. Superspreading events in the transmission dynamics of SARS-CoV-2: opportunities for interventions and control. PLoS Biol. 2020;18(11):e3000897.
Article CAS PubMed PubMed Central Google Scholar
Ritchie H, Roser M. UN Population Division, World Population Prospects, 2017 Revision. Age Structure. 2020 [Available from: https://ourworldindata.org/age-structure#how-does-median-age-vary-across-the-world]. Last access: 07/02/2023
Blumberg S, Lloyd-Smith JO. Inference of R0 and transmission heterogeneity from the size distribution of stuttering chains. PLOS Comput Biol. 2013;9(5):e1002993.
Article CAS PubMed PubMed Central Google Scholar
Zhang Y, Britton T, Zhou X. Monitoring real-time transmission heterogeneity from incidence data. PLoS Comput Biol. 2022;18(12):e1010078.
Download references
OW is fellow of the IMM-PACT-Programme for Clinician Scientists, Department of Medicine II, Medical Center – University of Freiburg and Faculty of Medicine, University of Freiburg, funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – 413517907.
AE is supported by Japan Society for the Promotion of Science (JSPS) Overseas Research Fellowships and JSPS Grants-in-Aid (KAKENHI, 22K17329).
Open Access funding enabled and organized by Projekt DEAL. The authors did not receive any funding for this project.
Institute for Immunodeficiency, Center for Chronic Immunodeficiency (CCI), Medical Center, Faculty of Medicine, University of Freiburg, Breisacherstr. 115, Freiburg, 79106, Germany
Oliver Wegehaupt
Clinic of Pediatric Hematology, Oncology and Stem Cell Transplantation, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany
Oliver Wegehaupt
Department of Global Health and Development, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK
Oliver Wegehaupt & Anna Vassall
Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK
Akira Endo
The Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, WC1E 7HT, UK
Akira Endo
School of Tropical Medicine and Global Health, Nagasaki University, Nagasaki, Japan
Akira Endo
Department of Global Health, The Academic Medical Center (AMC), The University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands
Anna Vassall
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
You can also search for this author in PubMed Google Scholar
OW carried out the systematic literature review and meta-analysis of data within the scope of an MSc programme in Public Health, wrote the manuscript and arranged figures. AE contributed to epidemiological calculations and manuscript revision. AV contributed to project development and manuscript revision. All authors approved the final version.
Correspondence to Oliver Wegehaupt.
There was no direct patient interaction or personal data involved in this study. It has been reviewed through the Combined Academic, Risk assessment and Ethics (CARE) process and approved by the London School of Hygiene & Tropical Medicine Ethics Committee.
Not applicable.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Critical appraisal criteria. B. Form for data extraction. C. Quality assessment by critical appraisal. D. Comparison of all-group mean k estimates by type of dataset.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Reprints and Permissions
Wegehaupt, O., Endo, A. & Vassall, A. Superspreading, overdispersion and their implications in the SARS-CoV-2 (COVID-19) pandemic: a systematic review and meta-analysis of the literature. BMC Public Health 23, 1003 (2023). https://doi.org/10.1186/s12889-023-15915-1
Download citation
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12889-023-15915-1
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
Advertisement
ISSN: 1471-2458
By using this website, you agree to our Terms and Conditions, Your US state privacy rights, Privacy statement and Cookies policy. Your privacy choices/Manage cookies we use in the preference centre.
© 2023 BioMed Central Ltd unless otherwise stated. Part of Springer Nature.